Aptamers Against COVID-19: An Untested Opportunity

被引:1
作者
Haberland, Annekathrin [1 ]
Mueller, Johannes [2 ]
机构
[1] Berlin Cures GmbH, Robert Rossle Str 10, D-13125 Berlin, Germany
[2] Berlin Cures GmbH, Knesebeckstr 59-61, D-10719 Berlin, Germany
关键词
Aptamer; BC; 007; COVID-19; long-COVID-19; multiple modes-of-action; SARS-CoV-2; SARS CORONAVIRUS; DNA APTAMERS; PROTEIN; COMPLEX; DOMAIN; AS1411;
D O I
10.2174/1389557522666220112094951
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Given the lack of success in the development of effective drugs to treat COVID-19, which show "game-changing" potential, it is necessary to explore drugs with different modes of action. Single mode-of-action drugs have not been succeeded in curing COVID-19, which is a highly complex disease. This is the case for direct antivirals and anti-inflammatory drugs, both of which treat different phases of the disease. Aptamers are molecules that deliver different modes of action, allowing their effects to be bundled, which, when combined, support their therapeutic efficacy. In this minireview, we summarise the current activities in the development of aptamers for the treatment of COVID-19 and long-COVID. A special emphasis is placed on the capability of their multiple modes of action, which is a promising approach for treating complex diseases such as COVID-19.
引用
收藏
页码:1708 / 1715
页数:8
相关论文
共 56 条
[1]   Aptamers in HIV research diagnosis and therapy [J].
Bala, Jyoti ;
Chinnapaiyan, Srinivasan ;
Dutta, Rajib Kumar ;
Unwalla, Hoshang .
RNA BIOLOGY, 2018, 15 (03) :327-337
[2]   A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects [J].
Becker, Niels-Peter ;
Haberland, Annekathrin ;
Wenzel, Katrin ;
Goettel, Peter ;
Wallukat, Gerd ;
Davideit, Hanna ;
Schulze-Rothe, Sarah ;
Hoenicke, Anne-Sophie ;
Schimke, Ingolf ;
Bartel, Sabine ;
Grossmann, Matthias ;
Sinn, Angela ;
Iavarone, Laura ;
Boergermann, Jan H. ;
Prilliman, Kiley ;
Golor, Georg ;
Mueller, Johannes ;
Becker, Susanne .
CLINICAL DRUG INVESTIGATION, 2020, 40 (05) :433-447
[3]  
Behbahani Mandana, 2021, Inform Med Unlocked, V26, P100757, DOI 10.1016/j.imu.2021.100757
[4]   Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19 [J].
Bhandari, Ranjana ;
Khanna, Garima ;
Kaushik, Dhriti ;
Kuhad, Anurag .
MOLECULAR NEUROBIOLOGY, 2021, 58 (07) :3347-3361
[5]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[6]   Heparin-Induced Thrombocytopenia in Severe COVID-19 [J].
Daviet, Florence ;
Guervilly, Christophe ;
Baldesi, Olivier ;
Bernard-Guervilly, Fanny ;
Pilarczyk, Estelle ;
Genin, Adrien ;
Lefebvre, Laurent ;
Forel, Jean Marie ;
Papazian, Laurent ;
Camoin-Jau, Laurence .
CIRCULATION, 2020, 142 (19) :1875-1877
[7]   AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin [J].
Girvan, Allicia C. ;
Teng, Yun ;
Casson, Lavona K. ;
Thomas, Shelia D. ;
Juliger, Simone ;
Ball, Mark W. ;
Klein, Jon B. ;
Pierce, William M., Jr. ;
Barve, Shirish S. ;
Bates, Paula J. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (07) :1790-1799
[8]   Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses [J].
Gonzalez, Victor M. ;
Elena Martin, M. ;
Fernandez, Geronimo ;
Garcia-Sacristan, Ana .
PHARMACEUTICALS, 2016, 9 (04)
[9]   Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap [J].
Gozzo, Lucia ;
Longo, Laura ;
Vitale, Daniela Cristina ;
Drago, Filippo .
FRONTIERS IN PHARMACOLOGY, 2020, 11
[10]   Aptamer BC 007-A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors [J].
Haberland, Annekathrin ;
Holtzhauer, Martin ;
Schlichtiger, Alice ;
Bartel, Sabine ;
Schimke, Ingolf ;
Mueller, Johannes ;
Dandel, Michael ;
Luppa, Peter B. ;
Wallukat, Gerd .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 789 :37-45